Compare iShares Core MSCI EAFE ETF (IEFA) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI EAFE ETF vs Intuitive Surgical, Inc. — how do they compare? iShares Core MSCI EAFE ETF trades at $96.52 (market cap $189.19B), while Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B). The key difference: iShares Core MSCI EAFE ETF is the larger of the two by market cap, and iShares Core MSCI EAFE ETF is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 40 Days and Intuitive Surgical, Inc. for 84 Days on average.
| IEFA | ISRG | |
|---|---|---|
Market Cap | $189.19B | $146.76B |
Volume | 8,441,787 | 2,529,814 |
Sector | Broad Market / Factor | Health |
52-Week High | $101.41 | $592.85 |
52-Week Low | $85.06 | $332.02 |
Typical Hold Time | 40 Days | 84 Days |
Enterprise Value | — | $141.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEFA, the iShares Core MSCI EAFE ETF, trades at $95.87, down 0.34% on the day, with a bearish technical signal driven by moving averages and oscillators. The fund provides exposure to developed markets outside North America, managing $196 billion in assets. Recent news highlights comparisons with competing international ETFs, noting its higher dividend yield and lower costs relative to some peers, though it has underperformed others on a total return basis over the past year.
The outlook for IEFA is mixed, offering diversification benefits and income through dividends but facing headwinds from weaker relative performance and bearish technical momentum. Key risks include concentration in developed markets, which may lag during global growth shifts, and expense ratio competition. Analyst sentiment is cautious due to recent underperformance versus broader global funds.
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core MSCI EAFE ETF
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
